№ files_lp_3_process_7_074180
File format: docx Character count: 5084 File size: 24 KB
Variants are listed for each exon of RPGR gene, classified based on genetic interpretation from PreventionGenetics and ClinVar.
Year: 2023
Region / City: N/A
Theme: Genetics / Variant Interpretation
Document Type: Table
Institution: PreventionGenetics
Author: N/A
Target Audience: Geneticists, Researchers
Period of Validity: N/A
Approval Date: N/A
Date of Changes: N/A
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.

Don’t have cryptocurrency yet?

You can still complete your purchase in a few minutes:
  1. Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
  2. In the app, tap Send.
  3. Select network, paste our wallet address.
  4. Send the exact amount shown above.
After sending, paste your TXID (transaction ID) and your email to receive the download link. Need help? Contact support and we’ll guide you step by step.

The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Monkey Survey of Urologists over the Management of Benign Prostatic Hyperplasia in India
Year: 2026
Country: India
Topic: Benign Prostatic Hyperplasia management
Document Type: Original Research Paper
Institution: World College of Medical Sciences & Research, Al-Falah School of Medical Sciences and Research, THSTI - DBT
Authors: Meghna Pandey, Shweta Sharma, Y.K Gupta, Dinesh Yadav, Komal
Target Audience: Urologists, medical researchers
Methodology: Survey-based study with 48 respondents
Key Drugs Studied: Tamsulosin, Silodosin, Alfuzosin, Dutasteride, Solifenacin, Tadalafil
Patient Demographics: Adult male patients with BPH
Data Collection Period: Not specified
Response Rate: 84.21%
Primary Outcome Measures: Preferred diagnostic methods, drug selection, adverse drug reactions, symptom improvement timeline
Secondary Outcomes: Fixed Dose Combinations and drug preferences in cardiac patients
Testosterone and PSA Dynamics in Benign Prostatic Hyperplasia and Prostate Cancer: Evidence from Patients at Lagos University Teaching Hospital, Nigeria
Year: 2024
Region / City: Lagos, Nigeria
Field: Urology, Oncology
Document Type: Research Article
Institution: Lagos University Teaching Hospital (LUTH)
Authors: Esomonu et al., Adhyam & Gupta, Ifere et al., Bhat et al., Lojanapiwat et al., Xu et al., Michaud et al., Glaser et al., Adebayo & Olaniyan, Ifionu et al.
Target Audience: Medical Researchers, Urologists, Oncologists
Study Period: January to September 2018
Approval Date: 2024
Keywords: Prostate Cancer, Benign Prostatic Hyperplasia, Prostate-Specific Antigen (PSA), Testosterone
Topics: RPGR PreventionGenetics Benign